Guidance

Diabetic eye screening: optical coherence tomography in surveillance

Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.

• From: NHS England
• Published: 8 July 2020
• Last updated: 27 September 2024 — See all updates

Applies to England

Documents

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics

HTML

[WITHDRAWN] Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics

Ref: PHE publications gateway number GW-1385

HTML

OCT examples

Ref: PHE publications gateway number GW-1385

HTML

Diabetic eye screening: OCT in surveillance pathway

Ref: PHE publications gateway number GW-1385

HTML

Details

This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).

This publication was previously published by Public Health England, which closed on 30 September 2021.

Published 8 July 2020
Last updated 27 September 2024 + show all updates

1. 27 September 2024

   Added clarification that publication was previously published by Public Health England.

2. 10 July 2024

   Removed PHE

3. 10 July 2024

   Updated guidance

4. 8 July 2020

   First published.